Chemed (NYSE:CHE) Stock Price Expected to Rise, Royal Bank of Canada Analyst Says

Chemed (NYSE:CHE) had its price objective upped by stock analysts at Royal Bank of Canada from $633.00 to $667.00 in a note issued to investors on Friday,Benzinga reports. The firm currently has an “outperform” rating on the stock. Royal Bank of Canada’s price target suggests a potential upside of 11.51% from the company’s previous close.

Separately, StockNews.com upgraded shares of Chemed from a “hold” rating to a “buy” rating in a research report on Friday, March 7th.

Chemed Stock Performance

NYSE CHE opened at $598.15 on Friday. Chemed has a one year low of $512.12 and a one year high of $654.62. The stock has a 50-day moving average of $560.28 and a 200 day moving average of $564.79. The company has a market capitalization of $8.76 billion, a price-to-earnings ratio of 30.22, a PEG ratio of 2.15 and a beta of 0.43.

Insider Buying and Selling

In other Chemed news, CEO Kevin J. Mcnamara sold 2,000 shares of the firm’s stock in a transaction that occurred on Thursday, March 6th. The shares were sold at an average price of $593.67, for a total transaction of $1,187,340.00. Following the sale, the chief executive officer now owns 102,679 shares in the company, valued at approximately $60,957,441.93. This trade represents a 1.91 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, VP Brian C. Judkins purchased 145 shares of the company’s stock in a transaction on Monday, December 30th. The stock was purchased at an average price of $519.50 per share, with a total value of $75,327.50. Following the completion of the transaction, the vice president now owns 1,678 shares of the company’s stock, valued at approximately $871,721. This trade represents a 9.46 % increase in their ownership of the stock. The disclosure for this purchase can be found here. 3.32% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Chemed

A number of institutional investors have recently bought and sold shares of CHE. UMB Bank n.a. boosted its stake in shares of Chemed by 300.0% in the fourth quarter. UMB Bank n.a. now owns 52 shares of the company’s stock worth $28,000 after acquiring an additional 39 shares during the period. Atala Financial Inc bought a new position in Chemed in the 4th quarter worth approximately $29,000. CBIZ Investment Advisory Services LLC grew its holdings in Chemed by 64.7% during the 4th quarter. CBIZ Investment Advisory Services LLC now owns 56 shares of the company’s stock valued at $30,000 after buying an additional 22 shares in the last quarter. Trust Co. of Vermont bought a new stake in shares of Chemed during the fourth quarter valued at approximately $34,000. Finally, Tortoise Investment Management LLC lifted its holdings in shares of Chemed by 77.3% in the fourth quarter. Tortoise Investment Management LLC now owns 78 shares of the company’s stock worth $41,000 after buying an additional 34 shares in the last quarter. Hedge funds and other institutional investors own 95.85% of the company’s stock.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.